Sofinnova Investments, Inc. Y M Abs Therapeutics, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.47 Billion
- Q2 2025
A detailed history of Sofinnova Investments, Inc. transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 2,194,278 shares of YMAB stock, worth $18.9 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
2,194,278
Previous 2,194,278
-0.0%
Holding current value
$18.9 Million
Previous $9.72 Million
1.81%
% of portfolio
0.67%
Previous 0.72%
Shares
2 transactions
Others Institutions Holding YMAB
# of Institutions
87Shares Held
25.7MCall Options Held
24KPut Options Held
0-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$36.5 Million0.89% of portfolio
-
Acorn Capital Advisors, LLC New York, NY3.42MShares$29.4 Million10.09% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$25.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$16.7 Million0.0% of portfolio
-
Polar Capital Holdings PLC London, X01.79MShares$15.4 Million0.05% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $376M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...